Grim-19 deficiency promotes decidual macrophage autophagy in recurrent spontaneous abortion

Yang Yang1,2, Haoran Liu2, Yue Zhao2

  • 1Key Laboratory for Experimental Teratology of Ministry of Education, Department of Anatomy and Histoembryology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.

Frontiers in Endocrinology
|November 17, 2022
PubMed

Insights

Grim-19 deficiency in decidual macrophages enhances autophagy and inflammation, potentially causing recurrent spontaneous abortion (RSA). This study reveals Grim-19

Area of Science:

  • Immunology and Reproductive Biology
  • Cellular and Molecular Mechanisms of Inflammation

Background:

  • Decidual macrophage dysregulation is linked to recurrent spontaneous abortion (RSA).
  • The specific role of macrophages in RSA pathogenesis remains largely undefined.

Purpose of the Study:

  • To investigate the role of Grim-19 in decidual macrophage function.
  • To elucidate the molecular mechanisms linking Grim-19 deficiency to RSA.
  • To explore the involvement of autophagy in Grim-19-mediated macrophage responses.

Main Methods:

  • Comparative analysis of decidual macrophages from RSA patients and normal pregnancy groups.
  • In vivo studies using GRIM-19 knockout mice and in vitro experiments with RAW264.7 and THP-1 cells.
  • siRNA-mediated inhibition of Grim-19, autophagy blockade, and RNA sequencing (RNA-seq).

Main Results:

  • Reduced Grim-19 expression and increased autophagy markers (Beclin1, LC3B II/I, BNIP3) in decidual macrophages of RSA patients.
  • Downregulation of Grim-19 in mice and cell lines elevated autophagy, proinflammatory cytokines (IL1B, IL6, TNFa), and phagocytic activity.
  • Autophagy blockade reversed the pro-inflammatory and phagocytic effects of Grim-19 deficiency in macrophages.

Conclusions:

  • Grim-19 deficiency impairs decidual macrophage function, promoting inflammation and phagocytosis, potentially via autophagy.
  • This mechanism represents a novel pathway contributing to the development of recurrent spontaneous abortion.
  • Targeting Grim-19 or autophagy pathways may offer therapeutic strategies for RSA.